NAF: Research Grants - Pioneer SCA3 Translational Awards
Funding Amount
US $100,000
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
From the program guidelines: “The Pioneer SCA3 Translational Research Award is annually granted to outstanding research proposals that aim to make significant advancements in the development of treatments and/or improvements to patient care for Spinocerebellar Ataxia Type 3 (SCA3).”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Applicants must have completed their post-doctoral training and have a full-time appointment as a faculty member, clinical fellow, or senior scientist at a research institution.
- Non-U.S. citizens are eligible to apply for a NAF grant award.
- Grant applications are accepted from U.S. and international institutions.
- Applicants are only eligible to submit one application per year.
Not eligible / not funded
- Not eligible: Individuals are ineligible if they were the lead PI on an awarded NAF grant within the past two fiscal years.
Overview
The National Ataxia Foundation (NAF) offers the Pioneer SCA3 Translational Awards to advance research on Spinocerebellar Ataxia Type 3 (SCA3). This annual grant, providing $100,000 for one year, supports innovative proposals aimed at improving treatments and patient care for SCA3. Eligible applicants include post-doctoral researchers with full-time faculty positions, including non-U.S. citizens. NAF prioritizes significant advancements in translational research while ensuring compliance with grant guidelines.
Overview
NAF works with the most knowledgeable, accomplished Ataxia researchers in the world.
The National Ataxia Foundation is committed to funding the best science relevant to hereditary and sporadic types of Ataxia in both basic and translational research. NAF invites research applications from domestic and International non-profit and for-profit institutions. Non-U.S. citizens are eligible to apply for some research grants from NAF, please check the PI Qualifications for more information.
The Pioneer SCA3 Translational Research Award is annually granted to outstanding research proposals that aim to make significant advancements in the development of treatments and/or improvements to patient care for Spinocerebellar Ataxia Type 3 (SCA3). Proposals may incorporate other forms of ataxia but must have a predominant focus on SCA3 translational or clinical research.
Funding
This 1-year award provides $100,000 in research funding that can be used to support direct research expenses. No more than 50% of the grant can be used to support personnel costs. Indirect costs and cost sharing are prohibited from being applied to NAF grants. No-cost extensions (NCE) will be considered for extenuating circumstances and are subject to approval by NAF. NAF retains the right to unilaterally cancel any awards for non-compliance or non-performance.
Eligibility
Applicants must have completed their post-doctoral training and have a full-time appointment as a faculty member, clinical fellow, or senior scientist at a research institution.Non-U.S. citizens are eligible to apply for a NAF grant award.Grant applications are accepted from U.S. and international institutions.Individuals are ineligible if they were the lead PI on an awarded NAF grant within the past two fiscal years.Applicants are only eligible to submit one application per year. Applicants should select the grant program that best suits their current position and proposal
What National Ataxia Foundation Incorporated actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 31
- Total given
- $1.83M
- Median grant
- $50K
- Range
- $5,600–$197K
- By dollars: California 14%, Minnesota 11%, Florida 11%. Top recipient cities: Chicago, IL; Boston, MA; Philadelphia, PA.
- 0% of grants with a stated purpose were for general or operating support.
- 35% of recipients were new grantees, not repeat recipients.
Example grants
Regents of the University of MN · Minneapolis, MN
Research
$197K
University of Chicago · Chicago, IL
Research
$122K
University of Texas Southwestern · Dallas, TX
Research
$111K
University of South Florida · Tampa, FL
Research
$103K
Columbia University New York · New York, NY
Research
$101K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Michael Lundquist Grant to Advance MSA-C Research
National Ataxia Foundation Incorporated
Amount
Up to US $50,000
Deadline
Deadline not published
DoW Arthritis Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
October 22, 2026
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
November 12, 2026
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,650,000 total
Deadline
October 22, 2026
DoW Arthritis Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$7,150,000 total
Deadline
October 22, 2026
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Ready to apply for NAF: Research Grants - Pioneer SCA3 Translational Awards?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found NAF: Research Grants - Pioneer SCA3 Translational Awards. Now let's win it.